Executive readout · one minute
Call research workspace
Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.
MTNB
$0.23
+0.43%
MTNB · Matinas BioPharma Holdings, Inc.
$0.23
+0.00 (+0.43%)
At close · Aug 14
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“We do not believe that our existing cash and cash equivalents will be sufficient to fund our operating expenses and capital requirements for a period of at least the next twelve months from the filing date of this Quarterly Report. As a result, substantial doubt exists about our ability to continue as a going concern.”View the 10-Q filed Aug 13, 2026
Market Cap
$3.44M
Shares
14.69M
All earnings calls
Earnings call · FY2019 Q4
Matinas BioPharma Holdings, Inc. Q4 FY2019 Earnings Call
Matinas BioPharma Holdings, Inc. Q4 FY2019 Earnings Call
Research coverage
2 live sources
Switch sources without leaving this page or losing your listening position.
Net income · derived Q4
-$5.57M
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Mar 9, 2020 · complete as-filed document
SEC periodic report
10-K report
Filed Mar 9, 2020 · complete as-filed document